Alto Neuroscience, Inc. ANRO

26.49 (0.69) (2.54%) as of 25 Sep
Market cap
$1.1B
P/E
0.0×

A Balance Sheet is a financial statement that provides a snapshot of a company's assets, liabilities, and shareholders' equity at a specific point in time. It follows the formula: Assets = Liabilities + Shareholders' Equity. Key components include current and non-current assets, current and long-term liabilities, and equity. The Balance Sheet helps businesses and investors evaluate financial stability, liquidity, and capital structure. It's essential for assessing the company's ability to meet its obligations and fund future operations.

Older periods Sep '25 Dec '25 Mar '26 Jun '26
Cash and Short Term Investments

+8 more quarters

137.82 176.48 263.76 243.73
Total current assets
139.45 177.72 269.13 247.32
Property, Plant, Equpment (Net)
2.03 1.87 2.23 2.05
Long-term assets (Other)
1.07 0.84 0.84 0.84
Total non-current assets
7.56 6.97 7.13 6.75
Total Assets
147.01 184.69 276.26 254.07
Accounts Payable
2.06 1.88 3.37 4.02
Accrued Expenses
6.99 8.86 7.61 8.86
Current Part of Debt
— 0.59 2.14 3.77
Total current liabilities
9.05 11.33 13.12 16.65
Long Term Debt (Total)
22.44 18.40 16.22 14.88
Total non-current liabilities
26.40 22.22 19.78 18.17
Total liabilities
35.45 33.55 32.89 34.82
Additional Paid In Capital
296.99 352.75 471.22 474.74
Common Stock (Net)
0.00 0.00 0.00 0.00
Retained Earnings
(185.45) (201.63) (227.87) (255.51)
Common Equity (Total)
111.56 151.14 243.37 219.25
Shareholders Equity (Total)
111.56 151.14 243.37 219.25
Shareholders Equity and Liabilities (Total)
147.01 184.69 276.26 254.07
Shares (Common)
27.17 31.92 35.05 35.09
Shareholders Equity (Tangible)
111.56 151.14 243.37 219.25
Net Debt
(115.38) (157.50) (245.41) (225.08)
Total Debt
22.44 18.98 18.36 18.65

Fold the line items

In millions of $ except per-share values · columns are period end dates